中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(6): 1082-1087

Pathological diagnosis of autoimmune hepatitis

DOI: 10.12449/JCH240603

  • Department of Pathology，The Affiliated Hospital of Hangzhou Normal University，Hangzhou 310015，China

More Information
  • Corresponding author: YANG Wenjun， yangwenjun3463@163.com （ORCID： 0000-0003-2021-595X）
  • Received Date: 2024-03-30
  • Accepted Date: 2024-05-15
  • Published Date: 2024-06-25
    Abstract

  • Autoimmune hepatitis （AIH） is an immune-mediated inflammatory disease of the liver parenchyma， which is characterized by hypergammaglobulinemia， the presence of autoantibodies， and typical abnormalities in liver histology； however， the diverse clinical manifestations of AIH and the lack of specific serological markers have brought difficulties and challenges in the diagnosis of AIH. Although portal lymphoplasmacytic infiltration， interface hepatitis， lymphocyte emperipolesis， and hepatocyte rosettes are the typical histological features of AIH， many other histological features can also be observed in AIH， including centrilobular necrosis and Kupffer cell hyaline globules. Therefore， no single histological feature can be used for the diagnosis of AIH， and a confirmed diagnosis should be made with reference to clinical and laboratory examinations， with the exclusion of liver diseases due to other causes. This article summarizes the histological features of AIH， different histopathological spectrum， common clinical issues， differential diagnosis， and recent advances.

     

    • FullText(HTML)
    • References(31)
  • [1]
    ZHANG XC, JAIN D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis[J]. Hum Pathol, 2023, 132: 114- 125. DOI: 10.1016/j.humpath.2022.06.019.
    [2]
    MANNS MP, CZAJA AJ, GORHAM JD, et al. Diagnosis and management of autoimmune hepatitis[J]. Hepatology, 2010, 51( 6): 2193- 2213. DOI: 10.1002/hep.23584.
    [3]
    MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases[J]. Hepatology, 2020, 72( 2): 671- 722. DOI: 10.1002/hep.31065.
    [4]
    SCIVERES M, NASTASIO S, MAGGIORE G. Novel diagnostic and therapeutic strategies in juvenile autoimmune hepatitis[J]. Front Pediatr, 2019, 7: 382. DOI: 10.3389/fped.2019.00382.
    [5]
    NASTASIO S, MOSCA A, ALTERIO T, et al. Juvenile autoimmune hepatitis: Recent advances in diagnosis, management and long-term outcome[J]. Diagnostics, 2023, 13( 17): 2753. DOI: 10.3390/diagnostics13172753.
    [6]
    GURUNG A, ASSIS DN, MCCARTY TR, et al. Histologic features of autoimmune hepatitis: A critical appraisal[J]. Hum Pathol, 2018, 82: 51- 60. DOI: 10.1016/j.humpath.2018.07.014.
    [7]
    FRANCESCHINI T, VASURI F, MURATORI P, et al. A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center[J]. Virchows Arch, 2021, 479( 5): 937- 945. DOI: 10.1007/s00428-021-03122-5.
    [8]
    ZHAO SX, LI WC, FU N, et al. Emperipolesis mediated by CD8+ T cells correlates with biliary epithelia cell injury in primary biliary cholangitis[J]. J Cell Mol Med, 2020, 24( 2): 1268- 1275. DOI: 10.1111/jcmm.14752.
    [9]
    LOHSE AW, SEBODE M, BHATHAL PS, et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology[J]. Liver Int, 2022, 42( 5): 1058- 1069. DOI: 10.1111/liv.15217.
    [10]
    AIZAWA Y, ABE H, SUGITA T, et al. Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol, 2016, 28( 4): 391- 397. DOI: 10.1097/MEG.0000000000000545.
    [11]
    UEDA K, AIZAWA Y, KINOSHITA C, et al. Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study[J]. Medicine, 2022, 101( 29): e29484. DOI: 10.1097/MD.0000000000029484.
    [12]
    CANH HN, HARADA K, OUCHI H, et al. Acute presentation of autoimmune hepatitis: A multicentre study with detailed histological evaluation in a large cohort of patients[J]. J Clin Pathol, 2017, 70( 11): 961- 969. DOI: 10.1136/jclinpath-2016-204271.
    [13]
    BIHARI C, RASTOGI A, SARIN SK. Postinfantile giant cell hepatitis: An etiological and prognostic perspective[J]. Hepat Res Treat, 2013, 2013: 601290. DOI: 10.1155/2013/601290.
    [14]
    KHEDR MA, ADAWY NM, SALIM TA, et al. Kupffer cell hyaline globules in children with autoimmune hepatitis[J]. J Clin Exp Hepatol, 2022, 12( 1): 20- 28. DOI: 10.1016/j.jceh.2021.04.013.
    [15]
    CZAJA AJ, CARPENTER HA. Autoimmune hepatitis with incidental histologic features of bile duct injury[J]. Hepatology, 2001, 34( 4 Pt 1): 659- 665. DOI: 10.1053/jhep.2001.27562.
    [16]
    MEHENDIRATTA V, MITROO P, BOMBONATI A, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2009, 7( 1): 98- 103. DOI: 10.1016/j.cgh.2008.08.043.
    [17]
    KHEDR MA, SALEM TA, BOGHDADI GM, et al. Seronegative autoimmune hepatitis in children: A real diagnostic challenge[J]. Wien Klin Wochenschr, 2022, 134( 5-6): 195- 201. DOI: 10.1007/s00508-021-01907-x.
    [18]
    HARTL J, MIQUEL R, ZACHOU K, et al. Features and outcome of AIH patients without elevation of IgG[J]. JHEP Rep, 2020, 2( 3): 100094. DOI: 10.1016/j.jhepr.2020.100094.
    [19]
    MONTANO-LOZA AJ, CARPENTER HA, CZAJA AJ. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis[J]. J Clin Gastroenterol, 2008, 42( 9): 1047- 1053. DOI: 10.1097/MCG.0b013e3181587d18.
    [20]
    de ROZA MA, LAMBA M, GOH GBB, et al. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study[J]. World J Gastroenterol, 2021, 27( 43): 7563- 7571. DOI: 10.3748/wjg.v27.i43.7563.
    [21]
    SUN SM, WANG YY, ZHANG Q, et al. Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease[J]. J Dig Dis, 2018, 19( 8): 498- 507. DOI: 10.1111/1751-2980.12646.
    [22]
    TAKAHASHI A, ARINAGA-HINO T, OHIRA H, et al. Nonalcoholic fatty liver disease in patients with autoimmune hepatitis[J]. JGH Open, 2018, 2( 2): 54- 58. DOI: 10.1002/jgh3.12046.
    [23]
    JOHNSON PJ, MCFARLANE IG. Meeting report: International autoimmune hepatitis group[J]. Hepatology, 1993, 18( 4): 998- 1005. DOI: 10.1002/hep.1840180435.
    [24]
    ALVAREZ F, BERG PA, BIANCHI FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31( 5): 929- 938. DOI: 10.1016/s0168-8278(99)80297-9.
    [25]
    HENNES EM, ZENIYA M, CZAJA AJ, et al. Simplified criteria for the diagnosis of autoimmune Hepatitis[J]. Hepatology, 2008, 48: 169- 176. DOI: 10.1002/hep.22322.
    [26]
    KABAÇAM G, WAHLIN S, EFE C. Autoimmune hepatitis triggered by COVID-19: A report of two cases[J]. Liver Int, 2021, 41( 10): 2527- 2528. DOI: 10.1111/liv.15044.
    [27]
    ŞENER AG, AYDıN N, CEYLAN C, et al. Investigation of antinuclear antibodies in chronic hepatitis B patients[J]. Mikrobiyol Bul, 2018, 52( 4): 425- 430. DOI: 10.5578/mb.67262.
    [28]
    ZHANG XC, OUYANG J, THUNG SN. Histopathologic manifestations of drug-induced hepatotoxicity[J]. Clin Liver Dis, 2013, 17( 4): 547- 564, vii-viii. DOI: 10.1016/j.cld.2013.07.004.
    [29]
    PATIL PA, ZHANG XC. Pathologic manifestations of gastrointestinal and hepatobiliary injury in immune checkpoint inhibitor therapy[J]. Arch Pathol Lab Med, 2021, 145( 5): 571- 582. DOI: 10.5858/arpa.2020-0070-RA.
    [30]
    SUZUKI A, BRUNT EM, KLEINER DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury[J]. Hepatology, 2011, 54( 3): 931- 939. DOI: 10.1002/hep.24481.
    [31]
    HONG-CURTIS J, YEH MMC, JAIN D, et al. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis[J]. J Clin Gastroenterol, 2004, 38( 10): 906- 909. DOI: 10.1097/00004836-200411000-00015.
    • Relative Articles

  • Relative Articles

    [1]Qiupeng WANG, Meifu GAN. Pathological diagnosis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1088-1092. doi: 10.12449/JCH240604
    [2]Jiping ZHANG. Pathological diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1093-1099. doi: 10.12449/JCH240605
    [3]Bin WANG. Pathological diagnosis of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1076-1081. doi: 10.12449/JCH240602
    [4]Xiaodong TENG. Value of biopsy in evaluating the pathological progression of autoimmune hepatitis/pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1073-1075. doi: 10.12449/JCH240601
    [5]Ke SUN. Pathological diagnosis of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1100-1106. doi: 10.12449/JCH240606
    [6]Xiaohan MA, Lixia YANG. Research advances in noninvasive diagnosis of liver fibrosis in autoimmune liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(11): 2689-2696. doi: 10.3969/j.issn.1001-5256.2023.11.026
    [7]Yu ZHANG, Yongfeng YANG. Thinking of the pathological diagnosis of unexplained liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 498-503. doi: 10.3969/j.issn.1001-5256.2023.03.003
    [8]Mengmeng ZHANG, Yao MENG, Xinyan ZHAO. Differential pathological diagnosis of liver tissue with normal appearance[J]. Journal of Clinical Hepatology, 2023, 39(3): 517-522. doi: 10.3969/j.issn.1001-5256.2023.03.006
    [9]Xinhang SONG, Juanhan YU, Zhaoping CHENG, Chen SHAO, Baocheng DENG. Pathological staging systems of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(3): 653-655. doi: 10.3969/j.issn.1001-5256.2022.03.033
    [10]Miao Qi, Chen XiaoYu. Liver histopathological diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 728-730. doi: 10.3969/j.issn.1001-5256.2020.04.003
    [11]Jiao DeChao, Lei QinYu, Han XinWei, Li ZongMing, Bi YongHua, Zhang QuanHui. Clinical value of ultra-thin electronic flexible endoscopy combined with intraluminal ultrasound in assisting percutaneous transhepatic biliary stricture biopsy[J]. Journal of Clinical Hepatology, 2019, 35(12): 2744-2747. doi: 10.3969/j.issn.1001-5256.2019.12.021
    [12]Yang YongFeng. Improve the knowledge of liver pathology and related skills among clinicians engaged in hepatology[J]. Journal of Clinical Hepatology, 2018, 34(11): 2267-2270. doi: 10.3969/j.issn.1001-5256.2018.11.001
    [13]Tian AiPing, Yang YongFeng. A comparative analysis of pathological grading and staging systems for chronic hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2271-2277. doi: 10.3969/j.issn.1001-5256.2018.11.002
    [14]Luo WenPing, Ma Hong, Zhao XinYan. Pathological features of hepatic vascular diseases and key points in differential diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2289-2294. doi: 10.3969/j.issn.1001-5256.2018.11.005
    [15]Jiang LiLin, Shen JianBo, Tang Hong, Lu ZhongHua. Pathological differential diagnosis of inflammatory liver injury[J]. Journal of Clinical Hepatology, 2018, 34(11): 2278-2282. doi: 10.3969/j.issn.1001-5256.2018.11.003
    [16]Wu DongBo, Chen EnQiang, Bai Lang, Tang Hong. Liver biopsy and related techniques in pathological diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2295-2299. doi: 10.3969/j.issn.1001-5256.2018.11.006
    [17]Chinese Society of Liver Cancer, Chinese Anti-Cancer Association, Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Pathology, Chinese Anti-Cancer Association, Digestive Disease Group, Chinese Society of Pathology, Chinese Medical Association, epatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Clinical Oncology, Chinese Anti-Cancer Association, Chinese Pathological Group of Hepatobiliary Tumor and Liver Transplantation. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China( 2015 update)[J]. Journal of Clinical Hepatology, 2015, 31(6): 833-839. doi: 10.3969/j.issn.1001-5256.2015.06.004
    [18]Shi MeiJie, Zhang ChaoZhen, Chi XiaoLing, Xie YuBao, Xiao HuanMing. Analysis of clinical high-risk factors for hepatitis B cirrhosis confirmed by liver biopsy[J]. Journal of Clinical Hepatology, 2014, 30(2): 149-152. doi: 10.3969/j.issn.1001-5256.2014.02.013
    [19]Lang ZhenWei. Pathological advances in autoimmune liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 326-331.
    [20]Ni Wei, Shi WeiQun. Clinical diagnosis and liver biopsy diagnosis of 97 cases with chronic HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 623-624+637.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 33.4 %FULLTEXT: 33.4 %META: 55.5 %META: 55.5 %PDF: 11.1 %PDF: 11.1 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 7.1 %其他: 7.1 %其他: 0.6 %其他: 0.6 %Prior Lake: 0.1 %Prior Lake: 0.1 %Saitama: 0.1 %Saitama: 0.1 %San Jose: 0.1 %San Jose: 0.1 %Tiruchi: 0.1 %Tiruchi: 0.1 %Wixom: 0.1 %Wixom: 0.1 %Yongin-si: 0.1 %Yongin-si: 0.1 %上海: 5.7 %上海: 5.7 %上饶: 0.7 %上饶: 0.7 %东莞: 0.1 %东莞: 0.1 %休斯敦: 0.1 %休斯敦: 0.1 %佛山: 0.3 %佛山: 0.3 %信阳: 0.2 %信阳: 0.2 %北京: 7.1 %北京: 7.1 %南京: 1.2 %南京: 1.2 %南宁: 0.1 %南宁: 0.1 %南通: 0.1 %南通: 0.1 %卡纳塔克: 0.3 %卡纳塔克: 0.3 %厦门: 0.1 %厦门: 0.1 %台州: 0.1 %台州: 0.1 %合肥: 0.6 %合肥: 0.6 %吉林: 0.1 %吉林: 0.1 %呼伦贝尔: 0.1 %呼伦贝尔: 0.1 %呼和浩特: 0.1 %呼和浩特: 0.1 %咸宁: 0.1 %咸宁: 0.1 %咸阳: 0.1 %咸阳: 0.1 %哈尔滨: 0.4 %哈尔滨: 0.4 %哥伦布: 0.1 %哥伦布: 0.1 %喀什: 0.2 %喀什: 0.2 %嘉兴: 0.1 %嘉兴: 0.1 %天水: 0.1 %天水: 0.1 %天津: 0.7 %天津: 0.7 %太原: 0.4 %太原: 0.4 %奥克维尔: 0.1 %奥克维尔: 0.1 %娄底: 0.3 %娄底: 0.3 %孟买: 0.1 %孟买: 0.1 %宁波: 0.4 %宁波: 0.4 %安康: 0.2 %安康: 0.2 %宜春: 0.3 %宜春: 0.3 %宣城: 0.1 %宣城: 0.1 %密蘇里城: 0.1 %密蘇里城: 0.1 %巴音郭楞: 0.2 %巴音郭楞: 0.2 %巴黎: 0.1 %巴黎: 0.1 %布里斯班: 0.2 %布里斯班: 0.2 %常州: 0.4 %常州: 0.4 %常德: 0.2 %常德: 0.2 %广州: 1.7 %广州: 1.7 %张家口: 2.5 %张家口: 2.5 %徐州: 0.1 %徐州: 0.1 %德里: 0.2 %德里: 0.2 %惠州: 0.2 %惠州: 0.2 %成都: 0.8 %成都: 0.8 %扬州: 0.1 %扬州: 0.1 %抚顺: 0.3 %抚顺: 0.3 %无锡: 0.6 %无锡: 0.6 %旧金山: 0.1 %旧金山: 0.1 %昆明: 1.2 %昆明: 1.2 %杭州: 2.4 %杭州: 2.4 %柳州: 0.1 %柳州: 0.1 %森尼韦尔: 0.1 %森尼韦尔: 0.1 %武汉: 1.4 %武汉: 1.4 %氹仔: 0.1 %氹仔: 0.1 %汕头: 0.1 %汕头: 0.1 %沈阳: 0.4 %沈阳: 0.4 %沧州: 0.1 %沧州: 0.1 %洛阳: 0.3 %洛阳: 0.3 %济南: 0.2 %济南: 0.2 %海口: 0.1 %海口: 0.1 %海得拉巴: 0.2 %海得拉巴: 0.2 %淄博: 0.3 %淄博: 0.3 %深圳: 0.5 %深圳: 0.5 %温哥华: 0.1 %温哥华: 0.1 %温州: 0.2 %温州: 0.2 %湘潭: 0.2 %湘潭: 0.2 %漯河: 0.3 %漯河: 0.3 %潍坊: 0.1 %潍坊: 0.1 %焦作: 0.2 %焦作: 0.2 %特洛伊: 0.1 %特洛伊: 0.1 %眉山: 0.1 %眉山: 0.1 %石家庄: 0.6 %石家庄: 0.6 %福州: 0.1 %福州: 0.1 %科泽科德: 0.1 %科泽科德: 0.1 %秦皇岛: 0.3 %秦皇岛: 0.3 %芒廷维尤: 23.5 %芒廷维尤: 23.5 %芝加哥: 1.3 %芝加哥: 1.3 %苏州: 0.1 %苏州: 0.1 %莫斯科: 0.6 %莫斯科: 0.6 %菏泽: 0.1 %菏泽: 0.1 %葵涌: 0.3 %葵涌: 0.3 %衡水: 0.1 %衡水: 0.1 %衡阳: 0.2 %衡阳: 0.2 %衢州: 0.2 %衢州: 0.2 %西宁: 9.6 %西宁: 9.6 %西安: 1.6 %西安: 1.6 %诺沃克: 0.1 %诺沃克: 0.1 %贵阳: 0.8 %贵阳: 0.8 %辽阳: 0.1 %辽阳: 0.1 %达州: 0.1 %达州: 0.1 %运城: 1.0 %运城: 1.0 %连云港: 0.1 %连云港: 0.1 %遵义: 0.1 %遵义: 0.1 %邯郸: 0.1 %邯郸: 0.1 %郑州: 0.5 %郑州: 0.5 %重庆: 0.5 %重庆: 0.5 %金华: 0.2 %金华: 0.2 %银川: 0.1 %银川: 0.1 %长春: 8.7 %长春: 8.7 %长沙: 1.3 %长沙: 1.3 %阿姆斯特丹: 0.1 %阿姆斯特丹: 0.1 %青岛: 0.7 %青岛: 0.7 %麻坡: 0.2 %麻坡: 0.2 %其他其他Prior LakeSaitamaSan JoseTiruchiWixomYongin-si上海上饶东莞休斯敦佛山信阳北京南京南宁南通卡纳塔克厦门台州合肥吉林呼伦贝尔呼和浩特咸宁咸阳哈尔滨哥伦布喀什嘉兴天水天津太原奥克维尔娄底孟买宁波安康宜春宣城密蘇里城巴音郭楞巴黎布里斯班常州常德广州张家口徐州德里惠州成都扬州抚顺无锡旧金山昆明杭州柳州森尼韦尔武汉氹仔汕头沈阳沧州洛阳济南海口海得拉巴淄博深圳温哥华温州湘潭漯河潍坊焦作特洛伊眉山石家庄福州科泽科德秦皇岛芒廷维尤芝加哥苏州莫斯科菏泽葵涌衡水衡阳衢州西宁西安诺沃克贵阳辽阳达州运城连云港遵义邯郸郑州重庆金华银川长春长沙阿姆斯特丹青岛麻坡

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (523) PDF downloads(105) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2941]YesterdayPV[5274]TodayIP[2021]TodayPV[3362]Online[88]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return